{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T23:54:30Z","timestamp":1787874870612,"version":"build-2784847793"},"reference-count":239,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:00:00Z","timestamp":1719446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Falk Medical Research Trust Catalyst Award","award":["GR118649"],"award-info":[{"award-number":["GR118649"]}]},{"name":"Falk Medical Research Trust Catalyst Award","award":["GR116012"],"award-info":[{"award-number":["GR116012"]}]},{"name":"Ron Foley Foundation Grant","award":["GR118649"],"award-info":[{"award-number":["GR118649"]}]},{"name":"Ron Foley Foundation Grant","award":["GR116012"],"award-info":[{"award-number":["GR116012"]}]},{"name":"Yale University Center for Genomic Analysis (YCGA) Pilot Grant","award":["GR118649"],"award-info":[{"award-number":["GR118649"]}]},{"name":"Yale University Center for Genomic Analysis (YCGA) Pilot Grant","award":["GR116012"],"award-info":[{"award-number":["GR116012"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Technological advancements in cell-free DNA (cfDNA) liquid biopsy have triggered exponential growth in numerous clinical applications. While cfDNA-based liquid biopsy has made significant strides in personalizing cancer treatment, the exploration and translation of epigenetics in liquid biopsy to clinical practice is still nascent. This comprehensive review seeks to provide a broad yet in-depth narrative of the present status of epigenetics in cfDNA liquid biopsy and its associated challenges. It highlights the potential of epigenetics in cfDNA liquid biopsy technologies with the hopes of enhancing its clinical translation. The momentum of cfDNA liquid biopsy technologies in recent years has propelled epigenetics to the forefront of molecular biology. We have only begun to reveal the true potential of epigenetics in both our understanding of disease and leveraging epigenetics in the diagnostic and therapeutic domains. Recent clinical applications of epigenetics-based cfDNA liquid biopsy revolve around DNA methylation in screening and early cancer detection, leading to the development of multi-cancer early detection tests and the capability to pinpoint tissues of origin. The clinical application of epigenetics in cfDNA liquid biopsy in minimal residual disease, monitoring, and surveillance are at their initial stages. A notable advancement in fragmentation patterns analysis has created a new avenue for epigenetic biomarkers. However, the widespread application of cfDNA liquid biopsy has many challenges, including biomarker sensitivity, specificity, logistics including infrastructure and personnel, data processing, handling, results interpretation, accessibility, and cost effectiveness. Exploring and translating epigenetics in cfDNA liquid biopsy technology can transform our understanding and perception of cancer prevention and management. cfDNA liquid biopsy has great potential in precision oncology to revolutionize conventional ways of early cancer detection, monitoring residual disease, treatment response, surveillance, and drug development. Adapting the implementation of liquid biopsy workflow to the local policy worldwide and developing point-of-care testing holds great potential to overcome global cancer disparity and improve cancer outcomes.<\/jats:p>","DOI":"10.3390\/cimb46070390","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T12:54:48Z","timestamp":1719579288000},"page":"6533-6565","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology"],"prefix":"10.3390","volume":"46","author":[{"given":"Wan Ying","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA"},{"name":"Department of Internal Medicine, Norwalk Hospital, Norwalk, CT 06850, USA"},{"name":"Hematology & Oncology, Neag Comprehensive Cancer Center, UConn Health, Farmington, CT 06030, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snigdha","family":"Nagabhyrava","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Norwalk Hospital, Norwalk, CT 06850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6840-8748","authenticated-orcid":false,"given":"Olivia","family":"Ang-Olson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paromita","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Ladel","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA"},{"name":"Department of Internal Medicine, Norwalk Hospital, Norwalk, CT 06850, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethsebie","family":"Sailo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"He","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita","family":"Ahuja","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yale School of Medicine, New Haven, CT 06520-8000, USA"},{"name":"Department of Pathology, Yale School of Medicine, New Haven, CT 06520-8000, USA"},{"name":"Biological and Biomedical Sciences Program (BBS), Yale University, New Haven, CT 06520-8084, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12943-022-01509-9","article-title":"Exosomes as a new frontier of cancer liquid biopsy","volume":"21","author":"Yu","year":"2022","journal-title":"Mol. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1038\/s41467-023-40680-5","article-title":"Mitochondria are secreted in extracellular vesicles when lysosomal function is impaired","volume":"14","author":"Liang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1038\/s41467-022-32995-6","article-title":"Cost-effective methylome sequencing of cell-free DNA for accurately detecting and locating cancer","volume":"13","author":"Stackpole","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: Mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/218525a0","article-title":"Towards a theoretical biology","volume":"218","author":"Waddington","year":"1968","journal-title":"Nature"},{"key":"ref_7","first-page":"18","article-title":"The epigenotype","volume":"1","author":"Waddington","year":"1942","journal-title":"Endeavour"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1126\/science.293.5532.1103","article-title":"Genes, genetics, and epigenetics: A correspondence","volume":"293","author":"Wu","year":"2001","journal-title":"Science"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1126\/science.294.5551.2477c","article-title":"Etymology of Epigenetics","volume":"294","author":"Rubin","year":"2001","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0029-1237423","article-title":"Epigenetics: Definition, mechanisms and clinical perspective","volume":"27","author":"Dupont","year":"2009","journal-title":"Semin. Reprod. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41568-018-0095-3","article-title":"Genomic evolution of cancer models: Perils and opportunities","volume":"19","author":"Beroukhim","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"eabh1275","DOI":"10.1126\/sciadv.abh1275","article-title":"Predicting and characterizing a cancer dependency map of tumors with deep learning","volume":"7","author":"Chiu","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbcan.2017.01.003","article-title":"Tumor evolution: Linear, branching, neutral or punctuated?","volume":"2","author":"Davis","year":"2017","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/01635581.2011.596642","article-title":"Alcohol consumption and cancer risk","volume":"63","author":"Pelucchi","year":"2011","journal-title":"Nutr. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"17420","DOI":"10.18632\/oncotarget.24724","article-title":"Impact of tobacco smoking on the risk of developing 25 different cancers in the UK: A retrospective study of 422,010 patients followed for up to 30 years","volume":"9","author":"Jacob","year":"2018","journal-title":"Oncotarget"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1365-4632.2010.04474.x","article-title":"Ultraviolet radiation and skin cancer","volume":"49","author":"Narayanan","year":"2010","journal-title":"Int. J. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e522","DOI":"10.1016\/S2468-2667(17)30192-5","article-title":"Risk of cancer associated with residential exposure to asbestos insulation: A whole-population cohort study","volume":"2","author":"Korda","year":"2017","journal-title":"Lancet Public Health"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eabg2538","DOI":"10.1126\/science.abg2538","article-title":"Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident","volume":"372","author":"Morton","year":"2021","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"i112","DOI":"10.1093\/jrr\/rrw005","article-title":"Epidemiological research on radiation-induced cancer in atomic bomb survivors","volume":"57","author":"Ozasa","year":"2016","journal-title":"J. Radiat. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/07357900701208733","article-title":"Carcinogenic food contaminants","volume":"25","author":"Abnet","year":"2007","journal-title":"Cancer Investig."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.tig.2014.04.004","article-title":"Mechanisms of epigenetic memory","volume":"30","author":"Brickner","year":"2014","journal-title":"Trend Genet."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Thiagalingam, S. (2020). Epigenetic memory in development and disease: Unraveling the mechanism. Biochim. Biophys. Acta Rev. Cancer, 2.","DOI":"10.1016\/j.bbcan.2020.188349"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/cncr.32052","article-title":"GIScience and cancer: State of the art and trends for cancer surveillance and epidemiology","volume":"125","author":"Sahar","year":"2019","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"7693","DOI":"10.1038\/s41598-024-57604-y","article-title":"Utilizing geospatial artificial intelligence to map cancer disparities across health regions","volume":"14","author":"Fadiel","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1002\/cncr.29345","article-title":"The impact of neighborhood social and built environment factors across the cancer continuum: Current research, methodological considerations, and future directions","volume":"121","author":"Gomez","year":"2015","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1158\/1055-9965.EPI-17-0104","article-title":"Geospatial Approaches to Cancer Control and Population Sciences","volume":"26","author":"Schootman","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s10620-024-08425-6","article-title":"Impact of Geospatial Food Access on Acute Pancreatitis Outcomes","volume":"22","author":"Chhoda","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/jnci\/94.10.755","article-title":"DNA Methylation and Environmental Exposures in Human Hepatocellular Carcinoma","volume":"94","author":"Shen","year":"2002","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"102561","DOI":"10.1016\/j.healthplace.2021.102561","article-title":"From social determinants to social epigenetics: Health geographies of chronic disease","volume":"69","author":"Shantz","year":"2021","journal-title":"Health Place"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41392-022-01251-0","article-title":"Aging and aging-related diseases: From molecular mechanisms to interventions and treatments","volume":"7","author":"Guo","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"(2022). The importance of aging in cancer research. Nat. Aging, 2, 365\u2013366.","DOI":"10.1038\/s43587-022-00231-x"},{"key":"ref_34","first-page":"835","article-title":"Aging, methylation and cancer","volume":"15","author":"Ahuja","year":"2000","journal-title":"Histol. Histopathol."},{"key":"ref_35","first-page":"5489","article-title":"Aging and DNA methylation in colorectal mucosa and cancer","volume":"58","author":"Ahuja","year":"1998","journal-title":"Cancer Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.14336\/AD.2017.0822","article-title":"Molecular Connections of Aging and Cancer","volume":"8","author":"Cho","year":"2017","journal-title":"Aging Dis."},{"key":"ref_37","first-page":"3573","article-title":"Accelerated age-related CpG island methylation in ulcerative colitis","volume":"61","author":"Issa","year":"2001","journal-title":"Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1040-8428(99)00019-0","article-title":"Aging, DNA methylation and cancer","volume":"32","author":"Issa","year":"1999","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","article-title":"CpG island methylator phenotype in colorectal cancer","volume":"96","author":"Toyota","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Yi, S.J., and Kim, K. (2020). New Insights into the Role of Histone Changes in Aging. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218241"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrclinonc.2017.166","article-title":"Tumour heterogeneity and resistance to cancer therapies","volume":"15","author":"Shaw","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Guo, M., Peng, Y., Gao, A., Du, C., and Herman, J.G. (2019). Epigenetic heterogeneity in cancer. Biomark. Res., 7.","DOI":"10.1186\/s40364-019-0174-y"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.chembiol.2023.09.013","article-title":"Inhibition of a lower potency target drives the anticancer activity of a clinical p38 inhibitor","volume":"30","author":"Bhattacharjee","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jamainternmed.2016.6008","article-title":"Failure of Investigational Drugs in Late-Stage Clinical Development and Publication of Trial Results","volume":"176","author":"Hwang","year":"2016","journal-title":"JAMA Intern. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"eaaw8412","DOI":"10.1126\/scitranslmed.aaw8412","article-title":"Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials","volume":"11","author":"Lin","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Beyes, S., Bediaga, N.G., and Zippo, A. (2021). An Epigenetic Perspective on Intra-Tumour Heterogeneity: Novel Insights and New Challenges from Multiple Fields. Cancers, 13.","DOI":"10.3390\/cancers13194969"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2013.03.008","article-title":"Interplay between the cancer genome and epigenome","volume":"153","author":"Shen","year":"2013","journal-title":"Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1146\/annurev-med-111314-035900","article-title":"Epigenetic Therapeutics: A New Weapon in the War Against Cancer","volume":"67","author":"Ahuja","year":"2016","journal-title":"Annu. Rev. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1172\/JCI69736","article-title":"Harnessing the potential of epigenetic therapy to target solid tumors","volume":"124","author":"Ahuja","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.trecan.2022.04.007","article-title":"Cellular and molecular mechanisms of plasticity in cancer","volume":"8","author":"Torborg","year":"2022","journal-title":"Trends Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.devcel.2022.04.005","article-title":"The role of senescence in cellular plasticity: Lessons from regeneration and development and implications for age-related diseases","volume":"57","author":"Ring","year":"2022","journal-title":"Dev. Cell"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Crouch, J., Shvedova, M., Thanapaul, R., Botchkarev, V., and Roh, D. (2022). Epigenetic Regulation of Cellular Senescence. Cells, 11.","DOI":"10.3390\/cells11040672"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41570-019-0108-0","article-title":"The chemistry of senescence","volume":"3","author":"Rovira","year":"2019","journal-title":"Nat. Rev. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","article-title":"Cancer cell plasticity during tumor progression, metastasis and response to therapy","volume":"4","author":"Blanpain","year":"2023","journal-title":"Nat. Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"eaaw3835","DOI":"10.1126\/science.aaw3835","article-title":"Epigenetics as a mediator of plasticity in cancer","volume":"379","author":"Feinberg","year":"2023","journal-title":"Science"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Urbanova, M., Buocikova, V., Trnkova, L., Strapcova, S., Kajabova, V.H., Melian, E.B., Novisedlakova, M., Tomas, M., Dubovan, P., and Earl, J. (2022). DNA Methylation Mediates EMT Gene Expression in Human Pancreatic Ductal Adenocarcinoma Cell Lines. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042117"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.1007\/s00018-016-2303-1","article-title":"Epigenetic regulation of epithelial-mesenchymal transition","volume":"73","author":"Sun","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1128\/MCB.01443-12","article-title":"SWI\/SNF chromatin-remodeling factor Smarcd3\/Baf60c controls epithelial-mesenchymal transition by inducing Wnt5a signaling","volume":"33","author":"Jordan","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Liu, Q.L., Luo, M., Huang, C., Chen, H.N., and Zhou, Z.G. (2021). Epigenetic Regulation of Epithelial to Mesenchymal Transition in the Cancer Metastatic Cascade: Implications for Cancer Therapy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.657546"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41419-019-1397-4","article-title":"EMT is associated with an epigenetic signature of ECM remodeling genes","volume":"10","author":"Peixoto","year":"2019","journal-title":"Cell Death Dis."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Adhikari, S., Bhattacharya, A., Adhikary, S., Singh, V., Gadad, S.S., Roy, S., and Das, C. (2022). The paradigm of drug resistance in cancer: An epigenetic perspective. Biosci. Rep., 42.","DOI":"10.1042\/BSR20211812"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer\u2014Clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_63","unstructured":"Nagaraju, G.P. (2019). Chapter 3\u2014EMT Contributes to Chemoresistance in Pancreatic Cancer. Breaking Tolerance to Pancreatic Cancer Unresponsiveness to Chemotherapy, Academic Press."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Wang, S., Prizment, A., Thyagarajan, B., and Blaes, A. (2021). Cancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment. Cancers, 13.","DOI":"10.3390\/cancers13030427"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ctrv.2020.102070","article-title":"KRAS: From undruggable to a druggable Cancer Target","volume":"89","author":"Uprety","year":"2020","journal-title":"Cancer Treat. Rev."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrg3270","article-title":"DNA methylation profiling in the clinic: Applications and challenges","volume":"13","author":"Heyn","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature14192","article-title":"Function and information content of DNA methylation","volume":"517","year":"2015","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature14248","article-title":"Integrative analysis of 111 reference human epigenomes","volume":"518","author":"Kundaje","year":"2015","journal-title":"Nature"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","article-title":"Epigenetic profiling to classify cancer of unknown primary: A multicentre, retrospective analysis","volume":"17","author":"Moran","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1101\/gr.119867.110","article-title":"A DNA methylation fingerprint of 1628 human samples","volume":"22","author":"Fernandez","year":"2012","journal-title":"Genome Res."},{"key":"ref_71","first-page":"14","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Neiman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1373\/clinchem.2017.272401","article-title":"DNA of Erythroid Origin Is Present in Human Plasma and Informs the Types of Anemia","volume":"63","author":"Lam","year":"2017","journal-title":"Clin. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.1038\/s41467-018-07466-6","article-title":"Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease","volume":"9","author":"Moss","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/CCO.0000000000000931","article-title":"Early Detection of Cancers in the Era of Precision Oncology","volume":"35","author":"Tan","year":"2023","journal-title":"Curr. Opin. Oncol."},{"key":"ref_75","first-page":"241","article-title":"[Nuclear Acids In Human Blood Plasma]","volume":"142","author":"Mandel","year":"1948","journal-title":"C. R. Seances Soc. Biol. Fil."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/0277-5379(87)90266-5","article-title":"Isolation and characterization of DNA from the plasma of cancer patients","volume":"23","author":"Stroun","year":"1987","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"ref_77","first-page":"12","article-title":"Circulating cell-free DNA for cancer early detection","volume":"3","author":"Gao","year":"2022","journal-title":"Innovation"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Ladel, L., Tan, W.Y., Jeyakanthan, T., Sailo, B., Sharma, A., and Ahuja, N. (2023). The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms. Cells, 12.","DOI":"10.3390\/cells12151962"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Inoue, F., Sone, K., Toyohara, Y., Takahashi, Y., Kukita, A., Hara, A., Taguchi, A., Tanikawa, M., Tsuruga, T., and Osuga, Y. (2021). Targeting Epigenetic Regulators for Endometrial Cancer Therapy: Its Molecular Biology and Potential Clinical Applications. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052305"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Han, M., Jia, L., Lv, W., Wang, L., and Cui, W. (2019). Epigenetic Enzyme Mutations: Role in Tumorigenesis and Molecular Inhibitors. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.00194"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Nemtsova, M.V., Kalinkin, A.I., Kuznetsova, E.B., Bure, I.V., Alekseeva, E.A., Bykov, I.I., Khorobrykh, T.V., Mikhaylenko, D.S., Tanas, A.S., and Strelnikov, V.V. (2021). Mutations in Epigenetic Regulation Genes in Gastric Cancer. Cancers, 13.","DOI":"10.3390\/cancers13184586"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2011-07-367961","article-title":"Mutant DNMT3A: A marker of poor prognosis in acute myeloid leukemia","volume":"119","author":"Ribeiro","year":"2012","journal-title":"Blood"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1056\/NEJMc1111708","article-title":"TET2 and DNMT3A mutations in human T-cell lymphoma","volume":"366","author":"Bastard","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ccr.2014.02.010","article-title":"The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers","volume":"25","author":"Spencer","year":"2014","journal-title":"Cancer Cell"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1073\/pnas.1400150111","article-title":"DNMT3A Arg882 mutation drives chronic myelomonocytic leukemia through disturbing gene expression\/DNA methylation in hematopoietic cells","volume":"111","author":"Xu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1074\/jbc.RA118.006795","article-title":"Mutations in the DNMT3A DNA methyltransferase in acute myeloid leukemia patients cause both loss and gain of function and differential regulation by protein partners","volume":"294","author":"Sandoval","year":"2019","journal-title":"J. Biol. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nm.4092","article-title":"An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation","volume":"22","author":"Souroullas","year":"2016","journal-title":"Nat. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.3109\/10428194.2015.1006220","article-title":"Strong expression of EZH2 and accumulation of trimethylated H3K27 in diffuse large B-cell lymphoma independent of cell of origin and EZH2 codon 641 mutation","volume":"56","author":"Zhou","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.187.4173.226","article-title":"DNA modification mechanisms and gene activity during development","volume":"187","author":"Holliday","year":"1975","journal-title":"Science"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: Islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Tollefsbol, T. (2011). Chapter 12\u2014Assessing Epigenetic Information. Handbook of Epigenetics, Academic Press.","DOI":"10.1016\/B978-0-12-375709-8.00001-0"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1073\/pnas.0510310103","article-title":"A genome-wide analysis of CpG dinucleotides in the human genome distinguishes two distinct classes of promoters","volume":"103","author":"Saxonov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e00348","DOI":"10.7554\/eLife.00348","article-title":"Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates","volume":"2","author":"Long","year":"2013","journal-title":"elife"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0888-7543(92)90024-M","article-title":"CpG islands as gene markers in the human genome","volume":"13","author":"Larsen","year":"1992","journal-title":"Genomics"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"11995","DOI":"10.1073\/pnas.90.24.11995","article-title":"Number of CpG islands and genes in human and mouse","volume":"90","author":"Antequera","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trend Genet."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF00286709","article-title":"Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma","volume":"83","author":"Greger","year":"1989","journal-title":"Hum. Genet."},{"key":"ref_99","first-page":"425","article-title":"DNA Methylation and Colorectal Cancer","volume":"10","author":"Ashktorab","year":"2014","journal-title":"Curr. Color. Cancer Rep."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1158\/0008-5472.CAN-08-0142","article-title":"Methylation of TFPI2 in stool DNA: A potential novel biomarker for the detection of colorectal cancer","volume":"69","author":"Dhir","year":"2009","journal-title":"Cancer Res."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Hoang, P.H., and Landi, M.T. (2022). DNA Methylation in Lung Cancer: Mechanisms and Associations with Histological Subtypes, Molecular Alterations, and Major Epidemiological Factors. Cancers, 14.","DOI":"10.3390\/cancers14040961"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Ma, L., Li, C., Yin, H., Huang, J., Yu, S., Zhao, J., Tang, Y., Yu, M., Lin, J., and Ding, L. (2023). The Mechanism of DNA Methylation and miRNA in Breast Cancer. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24119360"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Yang, M., Wang, S., Abbas, S.J., Zhang, J., Li, Y., Shao, R., and Liu, Y. (2022). An Overview of Epigenetic Methylation in Pancreatic Cancer Progression. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.854773"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-019-0650-0","article-title":"Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood","volume":"11","author":"Eissa","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-020-0648-8","article-title":"The DNA methylation landscape of advanced prostate cancer","volume":"52","author":"Zhao","year":"2020","journal-title":"Nat. Genet."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Shi, M., Tsui, S.K.-W., Wu, H., and Wei, Y. (2020). Pan-cancer analysis of differential DNA methylation patterns. BMC Med. Genom., 13.","DOI":"10.1186\/s12920-020-00780-3"},{"key":"ref_107","first-page":"761","article-title":"Comparative pan-cancer DNA methylation analysis reveals cancer common and specific patterns","volume":"18","author":"Yang","year":"2017","journal-title":"Brief. Bioinform."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00261-016-0798-4","article-title":"Emerging stool-based and blood-based non-invasive DNA tests for colorectal cancer screening: The importance of cancer prevention in addition to cancer detection","volume":"41","author":"Pickhardt","year":"2016","journal-title":"Abdom. Radiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(23)02830-1","article-title":"GRAIL-Galleri: Why the special treatment?","volume":"403","author":"Turnbull","year":"2024","journal-title":"Lancet"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tig.2015.10.007","article-title":"Lateral Thinking: How Histone Modifications Regulate Gene Expression","volume":"32","author":"Lawrence","year":"2016","journal-title":"Trend Genet."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41392-020-00252-1","article-title":"The role of histone methylation in the development of digestive cancers: A potential direction for cancer management","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Audia, J.E., and Campbell, R.M. (2016). Histone Modifications and Cancer. Cold Spring Harb. Perspect. Biol., 8.","DOI":"10.1101\/cshperspect.a019521"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: A dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Burlibasa, L., Nicu, A.T., Chifiriuc, M.C., Medar, C., Petrescu, A., Jinga, V., and Stoica, I. (2023). H3 histone methylation landscape in male urogenital cancers: From molecular mechanisms to epigenetic biomarkers and therapeutic targets. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1181764"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/bs.mie.2016.10.021","article-title":"Recent Achievements in Characterizing the Histone Code and Approaches to Integrating Epigenomics and Systems Biology","volume":"586","author":"Janssen","year":"2017","journal-title":"Methods Enzymol."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Zhao, Z., and Shilatifard, A. (2019). Epigenetic modifications of histones in cancer. Genome Biol., 20.","DOI":"10.1186\/s13059-019-1870-5"},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Singh, A.K., and Mueller-Planitz, F. (2021). Nucleosome Positioning and Spacing: From Mechanism to Function. J. Mol. Biol., 433.","DOI":"10.1016\/j.jmb.2021.166847"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41594-018-0166-x","article-title":"Nucleosome structure and dynamics are coming of age","volume":"26","author":"Zhou","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ydbio.2009.06.012","article-title":"Nucleosome positioning: How is it established, and why does it matter?","volume":"339","author":"Rando","year":"2010","journal-title":"Dev. Biol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nbt1279","article-title":"High-throughput mapping of the chromatin structure of human promoters","volume":"25","author":"Ozsolak","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2008.02.022","article-title":"Dynamic regulation of nucleosome positioning in the human genome","volume":"132","author":"Schones","year":"2008","journal-title":"Cell"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature10002","article-title":"Determinants of nucleosome organization in primary human cells","volume":"474","author":"Valouev","year":"2011","journal-title":"Nature"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41416-021-01635-z","article-title":"At the dawn: Cell-free DNA fragmentomics and gene regulation","volume":"126","author":"Liu","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1373\/clinchem.2005.049320","article-title":"Cell-Free DNA in Serum and Plasma: Comparison of ELISA and Quantitative PCR","volume":"51","author":"Holdenrieder","year":"2005","journal-title":"Clin. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2164-16-S13-S1","article-title":"Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation","volume":"16","author":"Ivanov","year":"2015","journal-title":"BMC Genom."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41525-018-0069-0","article-title":"New insights into structural features and optimal detection of circulating tumor DNA determined by single-strand DNA analysis","volume":"3","author":"Sanchez","year":"2018","journal-title":"NPJ Genom. Med."},{"key":"ref_128","doi-asserted-by":"crossref","unstructured":"Underhill, H.R., Kitzman, J.O., Hellwig, S., Welker, N.C., Daza, R., Baker, D.N., Gligorich, K.M., Rostomily, R.C., Bronner, M.P., and Shendure, J. (2016). Fragment Length of Circulating Tumor DNA. PLoS Genet., 12.","DOI":"10.1371\/journal.pgen.1006162"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Mouliere, F., Robert, B., Peyrotte, E.A., Del Rio, M., Ychou, M., Molina, F., Gongora, C., and Thierry, A.R. (2011). High fragmentation characterizes tumour-derived circulating DNA. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023418"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/s41586-019-1272-6","article-title":"Genome-wide cell-free DNA fragmentation in patients with cancer","volume":"570","author":"Cristiano","year":"2019","journal-title":"Nature"},{"key":"ref_131","first-page":"1659","article-title":"DNA fragments in the blood plasma of cancer patients: Quantitations and evidence for their origin from apoptotic and necrotic cells","volume":"61","author":"Jahr","year":"2001","journal-title":"Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Qi, T., Pan, M., Shi, H., Wang, L., Bai, Y., and Ge, Q. (2023). Cell-Free DNA Fragmentomics: The Novel Promising Biomarker. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021503"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"eaat4921","DOI":"10.1126\/scitranslmed.aat4921","article-title":"Enhanced detection of circulating tumor DNA by fragment size analysis","volume":"10","author":"Mouliere","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e15664","DOI":"10.1200\/JCO.2023.41.16_suppl.e15664","article-title":"Cell-free DNA fragmentation profiling for therapeutic response monitoring in metastatic colorectal cancer","volume":"41","author":"Skidmore","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Gianni, C., Palleschi, M., Merloni, F., Di Menna, G., Sirico, M., Sarti, S., Virga, A., Ulivi, P., Cecconetto, L., and Mariotti, M. (2022). Cell-Free DNA Fragmentomics: A Promising Biomarker for Diagnosis, Prognosis and Prediction of Response in Breast Cancer. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214197"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"101006","DOI":"10.1016\/j.gimo.2024.101006","article-title":"P125: Detection of pancreatic cancer in liquid biopsies using integrative fragmentomics","volume":"2","author":"Rahat","year":"2024","journal-title":"Genet. Med. Open"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Reyes, A.A., Marcum, R.D., and He, Y. (2021). Structure and Function of Chromatin Remodelers. J. Mol. Biol., 433.","DOI":"10.1016\/j.jmb.2021.166929"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbcan.2018.07.005","article-title":"ARID1A mutant ovarian clear cell carcinoma: A clear target for synthetic lethal strategies","volume":"1870","author":"Caumanns","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA)\u2014Rev. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev-pathmechdis-012418-012917","article-title":"SWI\/SNF Complex Mutations in Gynecologic Cancers: Molecular Mechanisms and Models","volume":"15","author":"Wang","year":"2020","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12935-023-03154-8","article-title":"The effects of ARID1A mutation in gastric cancer and its significance for treatment","volume":"23","author":"Lu","year":"2023","journal-title":"Cancer Cell Int."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1038\/s41467-023-43498-3","article-title":"SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Cooper, G.W., and Hong, A.L. (2022). SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities. Cancers, 14.","DOI":"10.3390\/cancers14153645"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/1093526617749671","article-title":"SMARCB1-deficient Tumors of Childhood: A Practical Guide","volume":"21","author":"Pawel","year":"2018","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Li, H., Gigi, L., and Zhao, D. (2023). CHD1, a multifaceted epigenetic remodeler in prostate cancer. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1123362"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature21357","article-title":"Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer","volume":"542","author":"Zhao","year":"2017","journal-title":"Nature"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature24046","article-title":"Nucleosome-Chd1 structure and implications for chromatin remodelling","volume":"550","author":"Farnung","year":"2017","journal-title":"Nature"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.gde.2004.02.001","article-title":"The functions of E(Z)\/EZH2-mediated methylation of lysine 27 in histone H3","volume":"14","author":"Cao","year":"2004","journal-title":"Curr. Opin. Genet. Dev."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Gan, L., Yang, Y., Li, Q., Feng, Y., Liu, T., and Guo, W. (2018). Epigenetic regulation of cancer progression by EZH2: From biological insights to therapeutic potential. Biomark. Res., 6.","DOI":"10.1186\/s40364-018-0122-2"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"6556","DOI":"10.1158\/1078-0432.CCR-12-3946","article-title":"EZH2 protein expression associates with the early pathogenesis, tumor progression, and prognosis of non-small cell lung carcinoma","volume":"19","author":"Behrens","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-1-61779-316-5_2","article-title":"DNA methylation detection: Bisulfite genomic sequencing analysis","volume":"791","author":"Li","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cca.2013.07.023","article-title":"Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events","volume":"425","author":"Keeley","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1586\/14737159.2014.943665","article-title":"The promise of methylation on beads for cancer detection and treatment","volume":"14","author":"Guzzetta","year":"2014","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/nar\/gkg249","article-title":"The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties","volume":"31","author":"Fraga","year":"2003","journal-title":"Nucleic. Acids Res."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Aberg, K.A., Xie, L., Chan, R.F., Zhao, M., Pandey, A.K., Kumar, G., Clark, S.L., and van den Oord, E.J. (2015). Evaluation of Methyl-Binding Domain Based Enrichment Approaches Revisited. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132205"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/nar\/gkp992","article-title":"MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome","volume":"38","author":"Serre","year":"2010","journal-title":"Nucleic. Acids Res."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/15592294.2019.1695339","article-title":"MBD-seq\u2014Realities of a misunderstood method for high-quality methylome-wide association studies","volume":"15","author":"Aberg","year":"2020","journal-title":"Epigenetics"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/epi.6.1.13313","article-title":"Comparison of methyl-DNA immunoprecipitation (MeDIP) and methyl-CpG binding domain (MBD) protein capture for genome-wide DNA methylation analysis reveal CpG sequence coverage bias","volume":"6","author":"Nair","year":"2011","journal-title":"Epigenetics"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1093\/bioinformatics\/btaa999","article-title":"FinaleDB: A browser and database of cell-free DNA fragmentation patterns","volume":"37","author":"Zheng","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13045-022-01342-z","article-title":"Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients","volume":"15","author":"Hallermayr","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: How to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J. Methodol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/bib\/bbv086","article-title":"Nucleosome positioning: Resources and tools online","volume":"17","author":"Teif","year":"2015","journal-title":"Brief. Bioinform."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1038\/s41596-021-00608-z","article-title":"Dual detection of chromatin accessibility and DNA methylation using ATAC-Me","volume":"16","author":"Guerin","year":"2021","journal-title":"Nat. Protoc."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJMoa2310336","article-title":"Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening","volume":"390","author":"Imperiale","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s40291-020-00473-8","article-title":"Epi proColon(\u00ae) for Colorectal Cancer Screening: A Profile of Its Use in the USA","volume":"24","author":"Shirley","year":"2020","journal-title":"Mol. Diagn. Ther."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/hep4.1918","article-title":"A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma","volume":"6","author":"Lin","year":"2022","journal-title":"Hepatol. Commun."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/nmat4997","article-title":"Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma","volume":"16","author":"Xu","year":"2017","journal-title":"Nat. Mater."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"e16588","DOI":"10.1200\/JCO.2023.41.16_suppl.e16588","article-title":"UriFind assay and association with whole course management of urothelial carcinoma in a large multicentric, prospective China cohort","volume":"41","author":"Chen","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13148-021-01029-1","article-title":"Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples","volume":"13","author":"Piatti","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jmoldx.2023.05.003","article-title":"Evaluation of Sensitive Urine DNA-Based PENK Methylation Test for Detecting Bladder Cancer in Patients with Hematuria","volume":"25","author":"Oh","year":"2023","journal-title":"J. Mol. Diagn."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","article-title":"Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set","volume":"32","author":"Klein","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41551-021-00746-5","article-title":"Ultrasensitive detection of circulating tumour DNA via deep methylation sequencing aided by machine learning","volume":"5","author":"Liang","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-019-0642-0","article-title":"Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA","volume":"11","author":"Han","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa2304714","article-title":"A Cell-free DNA Blood-Based Test for Colorectal Cancer Screening","volume":"390","author":"Chung","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1002\/cam4.868","article-title":"A cross-sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor-derived DNA with CEA for detection of recurrent colorectal cancer","volume":"5","author":"Young","year":"2016","journal-title":"Cancer Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1053\/j.gastro.2021.08.054","article-title":"A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer","volume":"161","author":"Cai","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13148-021-01216-0","article-title":"Circulating tumor DNA methylation marker MYO1-G for diagnosis and monitoring of colorectal cancer","volume":"13","author":"Lin","year":"2021","journal-title":"Clin. Epigenetics"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Lewin, J., Kottwitz, D., Aoyama, J., deVos, T., Garces, J., Hasinger, O., Kasielke, S., Knaust, F., Rathi, P., and Rausch, S. (2021). Plasma cell free DNA methylation markers for hepatocellular carcinoma surveillance in patients with cirrhosis: A case control study. BMC Gastroenterol., 21.","DOI":"10.1186\/s12876-021-01714-8"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1038\/s41467-023-39055-7","article-title":"A high-throughput test enables specific detection of hepatocellular carcinoma","volume":"14","author":"Cheishvili","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1097\/MPA.0000000000001919","article-title":"Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic Cancer","volume":"50","author":"Ying","year":"2021","journal-title":"Pancreas"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13148-023-01429-5","article-title":"Utility of promoter hypermethylation in malignant risk stratification of intraductal papillary mucinous neoplasms","volume":"15","author":"Chhoda","year":"2023","journal-title":"Clin. Epigenetics"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.euo.2018.06.011","article-title":"Performance of the Bladder EpiCheck\u2122 Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical Trial","volume":"1","author":"Witjes","year":"2018","journal-title":"Eur. Urol. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/JU.0000000000002748","article-title":"DNA Methylation Urine Biomarkers Test in the Diagnosis of Upper Tract Urothelial Carcinoma: Results from a Single-Center Prospective Clinical Trial","volume":"208","author":"Territo","year":"2022","journal-title":"J. Urol."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.juro.2015.08.085","article-title":"Evaluation of an Epigenetic Profile for the Detection of Bladder Cancer in Patients with Hematuria","volume":"195","author":"Lurkin","year":"2016","journal-title":"J. Urol."},{"key":"ref_185","first-page":"825","article-title":"Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates","volume":"40","author":"Dietrich","year":"2012","journal-title":"Int. J. Oncol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"e145973","DOI":"10.1172\/JCI145973","article-title":"Accurate diagnosis of pulmonary nodules using a noninvasive DNA methylation test","volume":"131","author":"Liang","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1093\/nar\/gky423","article-title":"CancerDetector: Ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"ref_188","doi-asserted-by":"crossref","unstructured":"Kang, S., Li, Q., Chen, Q., Zhou, Y., Park, S., Lee, G., Grimes, B., Krysan, K., Yu, M., and Wang, W. (2017). CancerLocator: Non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol., 18.","DOI":"10.1186\/s13059-017-1191-5"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1038\/s41467-020-17316-z","article-title":"Non-invasive early detection of cancer four years before conventional diagnosis using a blood test","volume":"11","author":"Chen","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Constantin, N., Sina, A.A., Korbie, D., and Trau, M. (2022). Opportunities for Early Cancer Detection: The Rise of ctDNA Methylation-Based Pan-Cancer Screening Technologies. Epigenomes, 6.","DOI":"10.3390\/epigenomes6010006"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0140-6736(23)01700-2","article-title":"Blood-based tests for multicancer early detection (PATHFINDER): A prospective cohort study","volume":"402","author":"Schrag","year":"2023","journal-title":"Lancet"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1158\/1538-7445.AM2023-3369","article-title":"Abstract 3369: Utility of ctDNA-based targeted methylation MRD assay for hematological malignancies","volume":"83","author":"Munugalavadla","year":"2023","journal-title":"Cancer Res."},{"key":"ref_193","unstructured":"(2024, April 03). GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research Annual Meeting. Available online: https:\/\/grail.com\/press-releases\/grail-presents-new-data-demonstrating-that-methylation-assay-detects-residual-hematologic-cancer-after-treatment-at-american-association-for-cancer-research-annual-meeting-2023\/."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3171\/2018.9.PEDS18419","article-title":"Impact of the H3K27M mutation on survival in pediatric high-grade glioma: A systematic review and meta-analysis","volume":"23","author":"Lu","year":"2018","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/nox149","article-title":"Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location","volume":"20","author":"Karremann","year":"2018","journal-title":"Neuro Oncol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1440-1827.2011.02776.x","article-title":"Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients","volume":"62","author":"Song","year":"2012","journal-title":"Pathol. Int."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"7237","DOI":"10.1158\/1078-0432.CCR-08-0869","article-title":"Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer","volume":"14","author":"Brambilla","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nature03672","article-title":"Global histone modification patterns predict risk of prostate cancer recurrence","volume":"435","author":"Seligson","year":"2005","journal-title":"Nature"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-08-3907","article-title":"Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome","volume":"69","author":"Elsheikh","year":"2009","journal-title":"Cancer Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1200\/JCO.2009.24.5639","article-title":"Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: Results from RTOG 9704","volume":"28","author":"Manuyakorn","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1245\/s10434-008-9927-9","article-title":"The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma","volume":"15","author":"Park","year":"2008","journal-title":"Ann. Surg. Oncol."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.annonc.2020.02.011","article-title":"Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA","volume":"31","author":"Liu","year":"2020","journal-title":"Ann. Oncol."},{"key":"ref_204","unstructured":"(2024, May 05). Galleri. Available online: https:\/\/www.galleri.com\/."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1158\/1078-0432.CCR-12-3224","article-title":"Novel methylation biomarker panel for the early detection of pancreatic cancer","volume":"19","author":"Yi","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","article-title":"Cancer epigenetics: From laboratory studies and clinical trials to precision medicine","volume":"10","author":"Yu","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13148-022-01419-z","article-title":"Drugging the epigenome in the age of precision medicine","volume":"15","author":"Feehley","year":"2023","journal-title":"Clin Epigenetics"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1038\/s41416-021-01321-0","article-title":"Achieving clinical success with BET inhibitors as anti-cancer agents","volume":"124","author":"Shorstova","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_209","doi-asserted-by":"crossref","unstructured":"Johnston, A.D., Ross, J.P., Ma, C., Fung, K.Y.C., and Locke, W.J. (2023). Epigenetic liquid biopsies for minimal residual disease, what\u2019s around the corner?. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1103797"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/cncr.32695","article-title":"Circulating epigenetic biomarkers for detection of recurrent colorectal cancer","volume":"126","author":"Symonds","year":"2020","journal-title":"Cancer"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/1878-0261.13178","article-title":"Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1\/IKZF1","volume":"16","author":"Symonds","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.humpath.2021.09.007","article-title":"Upper urothelial tract high-grade carcinoma: Comparison of urine cytology and DNA methylation analysis in urinary samples","volume":"118","author":"Pierconti","year":"2021","journal-title":"Hum. Pathol."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Fiorentino, V., Pizzimenti, C., Franchina, M., Rossi, E.D., Tralongo, P., Carlino, A., Larocca, L.M., Martini, M., Fadda, G., and Pierconti, F. (2023). Bladder Epicheck Test: A Novel Tool to Support Urothelial Carcinoma Diagnosis in Urine Samples. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241512489"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1196\/annals.1368.025","article-title":"Quantitative analysis of plasma DNA in colorectal cancer patients: A novel prognostic tool","volume":"1075","author":"Frattini","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_215","first-page":"4675","article-title":"Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients","volume":"61","author":"Sozzi","year":"2001","journal-title":"Cancer Res."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1158\/1541-7786.MCR-16-0044","article-title":"Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies","volume":"14","author":"Volik","year":"2016","journal-title":"Mol. Cancer Res."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"138","DOI":"10.6001\/actamedica.v24i2.3495","article-title":"Cell-free DNA in non-small cell lung cancer","volume":"24","author":"Schveigert","year":"2017","journal-title":"Acta Medica Litu."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-017-0564-y","article-title":"The Emerging Role of \u201cLiquid Biopsies,\u201d Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations","volume":"19","author":"Esposito","year":"2017","journal-title":"Curr. Oncol. Rep."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1093\/annonc\/mdz390","article-title":"Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer","volume":"30","author":"Tarazona","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"346ra92","DOI":"10.1126\/scitranslmed.aaf6219","article-title":"Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer","volume":"8","author":"Tie","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1158\/2159-8290.CD-17-0716","article-title":"Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling","volume":"7","author":"Chaudhuri","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.gene.2016.06.033","article-title":"Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study","volume":"590","author":"Yao","year":"2016","journal-title":"Gene"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cancergen.2017.08.006","article-title":"Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer","volume":"218\u2013219","author":"Vietsch","year":"2017","journal-title":"Cancer Genet."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nm.1789","article-title":"Circulating mutant DNA to assess tumor dynamics","volume":"14","author":"Diehl","year":"2008","journal-title":"Nat. Med."},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1515\/labmed-2022-0030","article-title":"The rising tide of cell-free DNA profiling: From snapshot to temporal genome analysis","volume":"46","author":"Bronkhorst","year":"2022","journal-title":"J. Lab. Med."},{"key":"ref_226","unstructured":"(2019). Molecular In Vitro Diagnostic Examinations\u2014Specifications for Pre-Examination Processes for Venous Whole Blood\u2014Part 3: Isolated Circulating Cell Free DNA from Plasma (Standard No. ISO 20186-3:2019)."},{"key":"ref_227","first-page":"00382","article-title":"Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care","volume":"8","author":"Febbo","year":"2024","journal-title":"JCO Precis. Oncol."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40273-023-01292-5","article-title":"Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature Review","volume":"41","author":"Fagery","year":"2023","journal-title":"Pharmacoeconomics"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"e2343392","DOI":"10.1001\/jamanetworkopen.2023.43392","article-title":"Cost-Effectiveness of Liquid Biopsy for Colorectal Cancer Screening in Patients Who Are Unscreened","volume":"6","author":"Aziz","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s40273-022-01181-3","article-title":"The Potential Value-Based Price of a Multi-Cancer Early Detection Genomic Blood Test to Complement Current Single Cancer Screening in the USA","volume":"40","author":"Tafazzoli","year":"2022","journal-title":"Pharmacoeconomics"},{"key":"ref_231","unstructured":"World Health Organization (2024, April 04). Global Cancer Burden Growing, Amidst Mounting Need for Services, Available online: https:\/\/www.who.int\/news\/item\/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services."},{"key":"ref_232","unstructured":"WHO (2024). WHO Global Survey on the Inclusion of Cancer Care in Health-Benefit Packages 2020\u20132021."},{"key":"ref_233","unstructured":"American Cancer Society (2024). Global Cancer Facts & Figures, American Cancer Society. [5th ed.]."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/bioinformatics\/btz809","article-title":"Network-based multi-task learning models for biomarker selection and cancer outcome prediction","volume":"36","author":"Wang","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1093\/bioinformatics\/btz769","article-title":"Deep-learning approach to identifying cancer subtypes using high-dimensional genomic data","volume":"36","author":"Chen","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"i389","DOI":"10.1093\/bioinformatics\/btz332","article-title":"Estimating the predictability of cancer evolution","volume":"35","author":"Hosseini","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1038\/s41598-024-56419-1","article-title":"Precision cancer classification using liquid biopsy and advanced machine learning techniques","volume":"14","author":"Eledkawy","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41416-022-02048-2","article-title":"Integrative analysis of multi-omics data for liquid biopsy","volume":"128","author":"Chen","year":"2023","journal-title":"Br. J. Cancer"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.aar3247","article-title":"Detection and localization of surgically resectable cancers with a multi-analyte blood test","volume":"359","author":"Cohen","year":"2018","journal-title":"Science"}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/46\/7\/390\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:06:18Z","timestamp":1760108778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/46\/7\/390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,27]]},"references-count":239,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["cimb46070390"],"URL":"https:\/\/doi.org\/10.3390\/cimb46070390","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,27]]}}}